Name of
Company
|
PT. KALBE FARMA, Tbk
|
||||||
Head Office
Address
|
Gedung Kalbe
Jl. Letjen.
Suprapto Kav. 4, Cempaka Putih,
Jakarta Pusat
10510 – Indonesia
Phone –
(62-21) 4287 3888 – 89
Fax - (62-21) 4287 3680
Website: www.kalbe.co.id
E-mail: info@kalbe.co.id
|
||||||
Factory
Address
|
Delta Silicon
Industrial Estate
Jl. MH
Thamrin, Blok A-3-1, Lippo Cikarang,
Bekasi 17037,
Propinsi Jawa Barat – Indonesia
Phone –
(62-21) 8990 7333 / 34, 8990 7337
Fax - (62-21) 897 2874
|
||||||
Date of
Establishment
|
·
10 September 1966 as PT.
Kalbe Farma
·
4 May 1998 as PT. Kalbe
Farma, Tbk
|
||||||
Start
Operation
|
1967
|
||||||
Legal Status
(latest)
|
The Minister
of Law and Human Rights
No.
AHU-13170.40.22.2014
Dated 12 June 2014
|
||||||
Category
|
Domestic
Investment Company (PMDN)
|
||||||
Government
Permits
|
Directorate
General of Taxation
Number of
Taxpayer – 01.001.836.4-092.000
|
||||||
Registered
Activities
|
SIC: 28
|
Chemical And
Allied Products
|
|||||
Business
Category
|
SIC: 283
|
Drugs
|
|||||
Line of
Business
|
SIC: 2843
|
Pharmaceutical
Preparations
|
|||||
Production
Capacity
|
Tablets
Capsules
Syrups
Cream
Injection
Eye Drop
Liquid in
Sachet
Dry Syrups
Caplets
Injection
Diagnostic
Kits
Veterinary
|
Approximately
7,900 million pcs
554 million pcs
40 million bottles
18.2 million ampoules
30 million ampoules
5.8 million bottles
300 million sachets
6.6 million bottles
482,500
million pcs
52.4 million vials
600,000 pcs
2,000 tons
|
|||||
Capitalization
|
Authorized
Capital
Issued
Capital
Paid up
Capital
|
Rp 850,000
million
Rp 468,751
million
Rp 468,751
million
|
|||||
Shareholders
|
·
PT. Gira Ira Sole
·
PT. Santa Seha Senada
·
PT. Diptanala Bahana
·
PT. Lucasta Murni
Cemerlang
·
PT. Ladang Ira Panen
·
PT. Bina Arta Charisma
·
Publics
|
10.17%
09.70%
09.49%
09.47%
09.21%
08.66%
43.30%
|
|||||
Investment
|
Not Available
|
||||||
Banking
|
·
Bank Negara Indonesia
·
Bank Central Asia
·
Bank Danamon
·
Bank Permata
·
Citibank
·
Others
|
||||||
Insurance
|
·
PT. Asuransi Mitra
Maparya
·
BPJS
|
||||||
Number of
Employees
|
Approximately
– 12,474 persons (as of March 2015)
|
||||||
Supervisory
Board
|
Pres.
Commissioner
|
Mr. Johanes
Setijono
|
|||||
Commissioners
|
Mr. Santoso
Oen
Mr. Josef
Darmawan Angkasa
Mr. Ferdinan
Aryanto
|
||||||
Independent
Comm.
|
Mr. Lucky
Surjadi Slamet
Mr. Farid
Anfasa Moeloek
|
||||||
Board of
Management
|
Pres.
Director
|
Mrs. BR
Irawaty Setiady
|
|||||
Directors
|
Mr. Budi Dharma Wreksoatmodjo
Mr. Ongkie Tedjasurja
Mr. Bujung Nugroho
Mr. Vidjongtius
|
||||||
Assets
|
2013
2014
2015
|
Rp 11,315,061
million
Rp 12,425,032
million
Rp 13,019,851
million (as of March 31, 2015)
|
|||||
Net Sales
|
2013
2014
2015
|
Rp
16,002,131 million
Rp 17,368,533
million
Rp 4,246,693
million (as of March 31, 2015)
|
|||||
Net Income
|
2013
2014
2015
|
Rp 2,004,244
million
Rp 2,129,215
million
Rp 549,518
million (as of March 31, 2015)
|
|||||
Credit Rating
|
“A (plus)”
|
||||||
Credit Risk
|
Very Strong
|
||||||
Related
Company
|
KALBE FARMA
Group
|
||||||
Date of Last
Research
|
30 June 2015
|
||||||
Posted by:
No comments:
Post a Comment